Plasmatology
Scope & Guideline
Advancing Plasma Science for a Brighter Future
Introduction
Aims and Scopes
- Biochemical Characterization:
Research focused on the biochemical properties and functional characteristics of plasma components, including growth factors, anticoagulants, and other proteins. - Clinical Applications:
Studies addressing the clinical use of plasma products in treating various conditions, including hematological diseases, immune disorders, and complications arising from treatments. - Innovative Therapeutic Strategies:
Exploration of new therapeutic approaches utilizing plasma, such as CRISPR technologies, plasma exchange techniques, and novel purification processes. - Public Health and Policy Insights:
Research evaluating the implications of plasma management in healthcare settings, including blood product utilization, health equity, and access to therapies. - Case Studies and Retrospective Analyses:
Detailed examinations of specific clinical cases or retrospective studies that provide insights into the effectiveness and challenges associated with plasma therapies.
Trending and Emerging
- Genetic and Molecular Approaches:
An increasing focus on genetic analysis and molecular mechanisms, such as CRISPR and other gene-editing technologies, showcases the integration of cutting-edge science into plasma therapy. - COVID-19 Related Research:
A significant rise in studies related to COVID-19, particularly the therapeutic use of convalescent plasma and vaccine-related antibody responses, reflects the pandemic's influence on plasma research. - Patient-Centric Studies:
A trend towards research that emphasizes patient outcomes, quality of life, and health equity indicates a growing recognition of the importance of patient perspectives in plasma-related therapies. - Interventional Studies:
There is a notable increase in clinical trials and interventional studies assessing the efficacy of plasma therapies for various diseases, highlighting a shift towards evidence-based practice in plasma medicine. - Public Health and Resource Management:
Emerging themes around the management of plasma resources, including ethical considerations and policy implications, suggest a growing emphasis on the systemic aspects of plasma utilization in healthcare.
Declining or Waning
- Historical Case Reports:
There has been a noticeable decrease in the publication of traditional case reports, as the journal appears to be focusing more on innovative research and broader clinical implications rather than isolated clinical narratives. - Basic Science Studies:
Research that delves into the fundamental science of plasma components without direct clinical application seems to be waning, possibly due to a preference for studies that bridge the gap between bench and bedside. - Exploratory Studies on Rare Conditions:
Investigations into less common plasma-related conditions or niche therapeutic applications are becoming less frequent, indicating a potential shift towards more prevalent clinical issues.
Similar Journals
Hematology Reports
Fostering collaboration in hematological research.Hematology Reports is an esteemed academic journal in the field of hematology, dedicated to advancing the understanding of blood disorders and their treatment. Published by MDPI, a leading Swiss publisher known for its commitment to open access since 2009, this journal provides a valuable platform for researchers and healthcare professionals to disseminate innovative findings and foster collaboration within the academic community. The journal features an array of articles ranging from clinical studies to laboratory research, and is indexed in Scopus, where it currently holds a rank of 113 out of 137 in the Medicine - Hematology category, placing it in the 17th percentile. As an open-access journal, Hematology Reports ensures that critical research is accessible to a global audience, supporting the dissemination of knowledge that has the potential to improve patient outcomes. This journal is an essential resource for those engaged in the study and treatment of hematological conditions, encouraging dialogue and the exchange of ideas to enhance clinical practices.
JOURNAL OF PLASMA PHYSICS
Illuminating the complexities of plasma behavior.Welcome to the JOURNAL OF PLASMA PHYSICS, a premier publication dedicated to advancing understanding and research in the field of plasma physics. Published by Cambridge University Press, this journal has been a pivotal resource since its inception in 1967, supporting scholars and professionals engaged in the innovative exploration of plasma phenomena. With an impressive Q1 rating in Condensed Matter Physics, the journal not only holds a significant position in the academic community but also ranks within the top 50th percentile in the Scopus database. Although it currently does not offer open access, the journal provides a wealth of valuable research contributions aimed at fostering knowledge and collaboration among researchers, professionals, and students alike. The Journal of Plasma Physics is committed to publishing high-quality articles that push the boundaries of knowledge, ensuring its vital role in the ever-evolving landscape of physics research.
Plasma
Fostering Collaboration in the Dynamic World of PlasmaPlasma is a leading open-access journal published by MDPI, devoted to the exploration and advancement of knowledge in the fields of engineering, physics, and materials science. Established in 2018, this journal provides a vital platform for researchers, professionals, and students to disseminate original findings and critical reviews related to plasma science, its applications, and its interdisciplinary aspects. With an E-ISSN of 2571-6182, Plasma actively promotes open access to ensure that research is widely accessible, reinforcing its commitment to accelerating scientific communication and collaboration across global communities. The journal enjoys respectable rankings in Scopus, with a notable position in Engineering, Physics and Astronomy, and Materials Science categories, making it an essential resource for those seeking to remain at the forefront of plasma research. Covering a range of topics until 2024, Plasma invites cutting-edge contributions that push the boundaries of understanding in this dynamic field.
Turkish Journal of Hematology
Innovating knowledge in the field of hematology since 1999.Turkish Journal of Hematology is an esteemed publication dedicated to advancing the field of hematology, producing influential research since its inception in 1999 under the auspices of GALENOS PUBL HOUSE. With an Open Access model, it facilitates widespread dissemination of knowledge, allowing researchers, clinicians, and students to stay abreast of the latest developments in blood disorders and treatments. With an ISSN of 1300-7777 and an E-ISSN of 1308-5263, the journal holds a commendable position in the academic community, evidenced by its 2023 Q3 ranking within the hematology category and its standing at #80 out of 137 in the Scopus database, placing it in the 41st percentile. Covering a wide scope of topics within hematology, this journal serves as a critical resource for disseminating innovative research and clinical practices pertinent to the ongoing challenges faced in this vital area of medicine. With its continuous publication until 2024, Turkish Journal of Hematology remains a beacon for enhancing the understanding and treatment of hematological conditions within the Turkish and global medical communities.
CURRENT OPINION IN HEMATOLOGY
Elevating hematology with expert reviews and analyses.CURRENT OPINION IN HEMATOLOGY is a leading peer-reviewed journal published by Lippincott Williams & Wilkins, focusing on the latest advancements and insights in the field of hematology. With an impressive impact factor and ranked in the first quartile (Q1) of its category, this journal serves as a vital resource for researchers, clinicians, and students seeking to stay informed on contemporary issues and emerging trends in hematological research and treatment. Established in 1994, it showcases critical reviews, expert commentary, and systematic analyses across a broad spectrum of hematology topics, contributing significantly to clinical and experimental knowledge through its robust editorial standards. While offering traditional subscription access, CURRENT OPINION IN HEMATOLOGY remains committed to providing a platform that bridges the gap between fundamental research and clinical application, making it indispensable for professionals dedicated to advancing patient care and scientific understanding in hematology.
CONTRIBUTIONS TO PLASMA PHYSICS
Fostering Innovative Insights in Plasma ScienceCONTRIBUTIONS TO PLASMA PHYSICS is a distinguished journal dedicated to advancing the field of plasma physics, published by WILEY-V C H VERLAG GMBH. Since its inception in 1988, this journal has provided a platform for high-quality research, fostering collaboration and dissemination of knowledge in the condensed matter physics domain. With its current ranking of Q3 in the 2023 assessments, the journal is recognized for its contributions to the discipline, as indicated by its position in the Scopus rankings (Rank #252/434) and 42nd percentile within its category. Researchers and professionals engaged in plasma physics are encouraged to submit their work, as the journal aims to publish innovative studies that push the boundaries of current understanding and application in plasma phenomena. While currently not offering open access, the journal remains a vital resource for insights into the complexities and advancements in plasma research, operating from its base in Germany.
Hematology-American Society of Hematology Education Program
Bridging Research and Practice in HematologyHematology-American Society of Hematology Education Program is a premier peer-reviewed journal dedicated to advancing the field of hematology through comprehensive educational content. Published by the American Society of Hematology, this journal plays a crucial role in disseminating knowledge to researchers, clinicians, and students in hematology and related disciplines. With an impressive Q1 status in the field, it ranks among the top journals at the forefront of hematological research, as evidenced by its 60th percentile ranking in Scopus' Medicine - Hematology category. Although it does not offer open access, the journal provides invaluable insights and educational resources from leading experts, focusing on the latest advancements, treatment protocols, and evolving understanding of blood disorders. Covering a wide range of topics, from basic research to clinical applications, this journal is essential for anyone seeking to deepen their expertise and stay informed on the latest developments in hematology. For further engagement, readers can access insightful articles published since 2001, ensuring a rich repository of knowledge for ongoing research and clinical excellence.
PLASMA SOURCES SCIENCE & TECHNOLOGY
Advancing the Frontiers of Plasma Science and Technology.PLASMA SOURCES SCIENCE & TECHNOLOGY is a premier academic journal published by IOP Publishing Ltd, focusing on the innovative field of plasma science and its applications in technology. Established in 1992, the journal has significantly contributed to advancing knowledge in this crucial area, maintaining a robust Q1 quartile ranking in Condensed Matter Physics as of 2023, which reflects its high-impact research dissemination. With an impressive Scopus ranking of 74 out of 434 in the field of Physics and Astronomy—specifically within Condensed Matter Physics—this journal stands out as a leading source for researchers and professionals dedicated to the study and application of plasma technologies. While it is not an Open Access journal, the published works are accessible through institutional subscriptions, making them available to a wide academic audience. The journal aims to provide a platform for significant contributions related to plasma physics, fostering scientific dialogue and collaboration across various disciplines. As it continues through its converged years up to 2024, PLASMA SOURCES SCIENCE & TECHNOLOGY remains essential for anyone involved in the burgeoning exploration of plasma-related scientific advancements.
Transfusionsmedizin
Innovating blood transfusion practices through research.Transfusionsmedizin is a premier journal dedicated to the field of transfusion medicine, published by the renowned GEORG THIEME VERLAG KG. With an ISSN of 2191-8805 and an E-ISSN of 2191-8813, this journal serves as a vital platform for disseminating cutting-edge research and clinical advancements in blood transfusion practices. Although it operates under a subscription model, the journal is committed to high-quality peer-reviewed content that addresses contemporary challenges and innovations in transfusion therapy. By fostering dialogue among researchers, clinicians, and students, Transfusionsmedizin aims to advance patient care and enhance the safety and efficacy of transfusion practices globally. Its contributions are essential for professionals engaged in transfusion science, hematology, and related medical fields, solidifying its reputation as a critical resource for staying abreast of the latest developments in transfusion research.
Mediterranean Journal of Hematology and Infectious Diseases
Connecting scholars to elevate hematology and infectious disease studies.Mediterranean Journal of Hematology and Infectious Diseases is a distinguished open access journal published by MATTIOLI 1885, dedicated to advancing the field of hematology and infectious diseases. Since its inception in 2009, the journal has provided a platform for researchers and practitioners to disseminate innovative findings, foster scholarly discourse, and enhance our understanding of these critical medical disciplines. With an impact factor reflecting its scholarly influence, it is recognized in the Q3 quartile for both Hematology and Infectious Diseases categories as of 2023. The journal's commitment to open access ensures that high-quality research is accessible to a global audience, contributing to the improvement of clinical practices and public health. Located in Fidenza, Italy, the journal continues to support converged research efforts from 2010 to 2024, making it an essential resource for academics, clinicians, and students in the medical community.